2 Results for "

PHA793887

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "PHA793887" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-11001
CAS No.: 718630-59-2
Purity:  99.25%
Target:  

CDK Caspase Apoptosis GSK-3

Research Areas:  

Cancer

PHA-793887 is a CDK inhibitor (with IC50 values of 8 nM for Cdk2, 60 nM for Cdk1, 62 nM for Cdk4, 138 nM for Cdk9). PHA-793887 inhibits purified GSK3β (IC50 79 nM). PHA-793887 reduces the phosphorylation level of nucleophosmin/cdc6, induces G1/G2/M phase arrest, and triggers Apoptosis by activating Caspase-3. PHA-793887 exhibits anticancer activity against leukemia. PHA-793887 can be used in research related to acute leukemia, chronic myeloid leukemia, and advanced/metastatic solid tumors .
loading...
    loading...
Cat. No.: HY-11001A
CAS No.: 718630-60-5
Target:  

CDK Caspase Apoptosis GSK-3

Research Areas:  

Cancer

PHA-793887 hydrochloride is a CDK inhibitor (with IC50 values of 8 nM for Cdk2, 60 nM for Cdk1, 62 nM for Cdk4, 138 nM for Cdk9). PHA-793887 hydrochloride inhibits purified GSK3β (IC50 79 nM). PHA-793887 hydrochloride reduces the phosphorylation level of nucleophosmin/cdc6, induces G1/G2/M phase arrest, and triggers Apoptosis by activating Caspase-3. PHA-793887 hydrochloride exhibits anticancer activity against leukemia. PHA-793887 hydrochloride can be used in research related to acute leukemia, chronic myeloid leukemia, and advanced/metastatic solid tumors .
loading...
    loading...